dc.contributor.author
Gollrad, Johannes
dc.contributor.author
Korpusik, Nevenka
dc.contributor.author
Rabsahl, Christopher
dc.contributor.author
Boehmer, Dirk
dc.contributor.author
Besserer, Angela
dc.contributor.author
Grittner, Ulrike
dc.contributor.author
Boeker, Alexander
dc.contributor.author
Keilholz, Ulrich
dc.contributor.author
Joussen, Antonia
dc.contributor.author
Budach, Volker
dc.contributor.author
Goerling, Ute
dc.date.accessioned
2024-10-28T17:53:31Z
dc.date.available
2024-10-28T17:53:31Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/45429
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-45141
dc.description.abstract
Background: Cytogenetic testing (CGT) in uveal melanoma patients reveals prognostic information about the individual risk of developing distant metastasis with dismal prognosis. There is currently no medical intervention strategy with proven effect on the prognosis, rendering the result of the cytogenetic testing purely informative. We explored patients' socio-demographic backgrounds, psychological preconditions, coping strategies, external influences, and concerns about "knowing their fate" to study their possible interactions with decision-making for CGT.
Methods: Uveal melanoma patients were asked to complete questionnaires on their interest in undergoing CGT for prognostication and the factors influencing their decision. Data were collected on socio-demographics, baseline anxiety (GAD-7), depression (PHQ-9), coping strategies (Brief COPE), and assumed future concerns regarding the CGT result. Data were analyzed by using multiple ordinal logistic regression and exploring estimated marginal effects.
Results: Questionnaires were returned by 121 of 131 (92.4%) patients. Fifty-two patients (43%) had no interest in CGT, 34 (28.1%) were undecided, and 35 (28.9%) were interested. We observed no significant differences regarding age, sex, partnership, education, occupation, baseline anxiety, or depression. Decision-making favoring CGT was influenced by the treating physicians, internet resources, and level of baseline anxiety. Patients were likely to reject CGT when they worried that "knowing the result will have an unintended influence" on their life.
Conclusion: Decision-making about CGT for prognostication in uveal melanoma is burdensome to many patients and in general not guided by medical advice regarding further treatment and screening procedures. The psychological impact of the decision is therefore unique and requires careful support by psycho-oncologists considering the patient's fears and expectations.
en
dc.rights.uri
https://creativecommons.org/licenses/by/4.0/
dc.subject
Cytogenetic testing
en
dc.subject
Uveal melanoma
en
dc.subject
Cancer prognosis
en
dc.subject
Proton therapy
en
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit
dc.title
Fear of prognosis? How anxiety, coping, and expected burden impact the decision to have cytogenetic assessment in uveal melanoma patients
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.doi
10.1007/s00520-022-07006-5
dcterms.bibliographicCitation.journaltitle
Supportive Care in Cancer
dcterms.bibliographicCitation.number
7
dcterms.bibliographicCitation.originalpublishername
Springer Nature
dcterms.bibliographicCitation.pagestart
5837
dcterms.bibliographicCitation.pageend
5847
dcterms.bibliographicCitation.volume
30
refubium.affiliation
Charité - Universitätsmedizin Berlin
refubium.funding
Springer Nature DEAL
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.bibliographicCitation.pmid
35355121
dcterms.isPartOf.issn
0941-4355
dcterms.isPartOf.eissn
1433-7339